FSD Pharma Inc. (HUGE) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

FSD Pharma Inc.

HUGE

NASDAQ

Unprofitable

66671

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Aug 2025

66671

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Aug 2025

0.09USD

-0.01 ( -10.10%)

Market Closed (as of Aug 14, 20:00 EDT)

Relative Strenght

Volume Buzz

11123%

Earning Acce

Dist 52w H.

100%

Overview Chart

Quote Panel

Updated June 13, 2025

1W % 1M % 3M % 1Y -72.60 %

Key Metrics

Market Cap
66671
Shares Outstanding
741612
Share in Float
600696
Dividende
0

Earning Date
12 Aug 2025
Price Target
0.0899
Average Volume
196163
Beta
0.848

Range
0.087-109.1935
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.fsdpharma.com
Sector
Healthcare

Quote Panel

Updated June 13, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

0.53x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-16.3

EPS

How HUGE compares to sector?

P/E Ratio

Fundamentals

Relative Strength

HUGE

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

HUGE

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$9M

NaN%

2025-Revenue

$0.17

-256%

2025-EPS

$5M

262%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-0.19
vs -0.15

Q4.22

N/A

-0.16
vs -0.18

Q1.23

N/A

-0.26
vs -0.14

Q2.23

N/A

-0.14
vs -0.21

Q3.23

N/A

-0.03
vs -0.19

Q4.23

N/A

-0.04
vs -0.16

Q1.24

N/A

-0.05
vs -0.26

Q2.24

N/A

-0.08
vs -0.14

Q3.24

N/A

-0.08
vs -0.03

Q4.24

N/A

-0.07
vs -0.04

Sales Growth

YoY

Current

Estimates

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

NA vs NA

Q1.24

NA vs NA

Q2.24

NA vs NA

Q3.24

707K vs NA

Q4.24

945.4K vs NA

Return on Equity

QoQ

Q3.22

-20%

-0.20
vs -0.11

Q4.22

-19%

-0.19
vs -0.20

Q1.23

-52%

-0.52
vs -0.19

Q2.23

-54%

-0.54
vs -0.52

Q3.23

-8%

-0.08
vs -0.54

Q4.23

-13%

-0.13
vs -0.08

Q1.24

-16%

-0.16
vs -0.13

Q2.24

-28%

-0.28
vs -0.16

Institutionnal Ownership

QoQ

Q1.22

23
vs 27

-15%

Q2.22

18
vs 23

-22%

Q3.22

16
vs 18

-11%

Q4.22

18
vs 16

13%

Q1.23

17
vs 18

-6%

Q2.23

13
vs 17

-24%

Q3.23

18
vs 13

38%

Q4.23

1
vs 18

-94%

Earnings Growth

Latest News

accessnewswire.com

7 hours ago

Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

accesswire.com

7 hours ago

Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation

accesswire.com

7 hours ago

FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team

newsfilecorp.com

9 hours ago

24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma

investorplace.com

10 hours ago

FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock?

newsfilecorp.com

20 hours ago

FSD Pharma Announces Share Consolidation and Name Change

Company Description

0.09USD

N/A

0.00x

0.53x

0.1

0.0%

$-16.3

$9M

$0.17

$5M

Earnings Growth

Latest News

$9M

$0.17

$5M

Company Description

0.09USD

N/A

0.00x

0.53x

0.1

0.0%

$-16.3